Symbol
RPTX
Investment type
Equity / Common shares, no par value
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

BIOTECHNOLOGY VALUE FUND L P ownership in Repare Therapeutics Inc. Common shares, no par value (RPTX)

30 Jan 2026 - BIOTECHNOLOGY VALUE FUND L P has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Repare Therapeutics Inc. Common shares, no par value (RPTX). This represents 0% ownership of the company. In their previous filing dated 24 Nov 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 10,333,600 shares, indicating a decrease of +100%. .